UniProt ID | BC11B_HUMAN | |
---|---|---|
UniProt AC | Q9C0K0 | |
Protein Name | B-cell lymphoma/leukemia 11B | |
Gene Name | BCL11B | |
Organism | Homo sapiens (Human). | |
Sequence Length | 894 | |
Subcellular Localization | Nucleus . | |
Protein Description | Key regulator of both differentiation and survival of T-lymphocytes during thymocyte development in mammals. Essential in controlling the responsiveness of hematopoietic stem cells to chemotactic signals by modulating the expression of the receptors CCR7 and CCR9, which direct the movement of progenitor cells from the bone marrow to the thymus. [PubMed: 27959755 Is a regulator of IL2 promoter and enhances IL2 expression in activated CD4(+) T-lymphocytes] | |
Protein Sequence | MSRRKQGNPQHLSQRELITPEADHVEAAILEEDEGLEIEEPSGLGLMVGGPDPDLLTCGQCQMNFPLGDILVFIEHKRKQCGGSLGACYDKALDKDSPPPSSRSELRKVSEPVEIGIQVTPDEDDHLLSPTKGICPKQENIAGPCRPAQLPAVAPIAASSHPHSSVITSPLRALGALPPCLPLPCCSARPVSGDGTQGEGQTEAPFGCQCQLSGKDEPSSYICTTCKQPFNSAWFLLQHAQNTHGFRIYLEPGPASSSLTPRLTIPPPLGPEAVAQSPLMNFLGDSNPFNLLRMTGPILRDHPGFGEGRLPGTPPLFSPPPRHHLDPHRLSAEEMGLVAQHPSAFDRVMRLNPMAIDSPAMDFSRRLRELAGNSSTPPPVSPGRGNPMHRLLNPFQPSPKSPFLSTPPLPPMPPGGTPPPQPPAKSKSCEFCGKTFKFQSNLIVHRRSHTGEKPYKCQLCDHACSQASKLKRHMKTHMHKAGSLAGRSDDGLSAASSPEPGTSELAGEGLKAADGDFRHHESDPSLGHEPEEEDEEEEEEEEELLLENESRPESSFSMDSELSRNRENGGGGVPGVPGAGGGAAKALADEKALVLGKVMENVGLGALPQYGELLADKQKRGAFLKRAAGGGDAGDDDDAGGCGDAGAGGAVNGRGGGFAPGTEPFPGLFPRKPAPLPSPGLNSAAKRIKVEKDLELPPAALIPSENVYSQWLVGYAASRHFMKDPFLGFTDARQSPFATSSEHSSENGSLRFSTPPGDLLDGGLSGRSGTASGGSTPHLGGPGPGRPSSKEGRRSDTCEYCGKVFKNCSNLTVHRRSHTGERPYKCELCNYACAQSSKLTRHMKTHGQIGKEVYRCDICQMPFSVYSTLEKHMKKWHGEHLLTNDVKIEQAERS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Phosphorylation | ------MSRRKQGNP ------CCCCCCCCH | 40.57 | 26074081 | |
13 | Phosphorylation | QGNPQHLSQRELITP CCCHHHCCCCCCCCC | 25.68 | 26074081 | |
19 | Phosphorylation | LSQRELITPEADHVE CCCCCCCCCCCCHHH | 27.92 | 26074081 | |
79 | Ubiquitination | VFIEHKRKQCGGSLG EEEEECCHHCCCCCH | 55.53 | - | |
79 (in isoform 2) | Ubiquitination | - | 55.53 | - | |
84 | Phosphorylation | KRKQCGGSLGACYDK CCHHCCCCCHHHHHH | 14.65 | 30576142 | |
89 | Phosphorylation | GGSLGACYDKALDKD CCCCHHHHHHHHCCC | 21.68 | 26074081 | |
91 | Ubiquitination | SLGACYDKALDKDSP CCHHHHHHHHCCCCC | 25.11 | - | |
95 | Ubiquitination | CYDKALDKDSPPPSS HHHHHHCCCCCCCCC | 62.04 | - | |
97 | Phosphorylation | DKALDKDSPPPSSRS HHHHCCCCCCCCCHH | 45.08 | 23401153 | |
101 | Phosphorylation | DKDSPPPSSRSELRK CCCCCCCCCHHHHHH | 44.12 | 23403867 | |
102 | Phosphorylation | KDSPPPSSRSELRKV CCCCCCCCHHHHHHC | 45.67 | 23403867 | |
104 | Phosphorylation | SPPPSSRSELRKVSE CCCCCCHHHHHHCCC | 42.82 | 23403867 | |
108 | Ubiquitination | SSRSELRKVSEPVEI CCHHHHHHCCCCEEE | 63.84 | - | |
110 | Phosphorylation | RSELRKVSEPVEIGI HHHHHHCCCCEEEEE | 38.94 | 26074081 | |
120 | Phosphorylation | VEIGIQVTPDEDDHL EEEEEEECCCCCCCC | 14.51 | 30266825 | |
129 | Phosphorylation | DEDDHLLSPTKGICP CCCCCCCCCCCCCCC | 36.56 | 30266825 | |
129 (in isoform 2) | Phosphorylation | - | 36.56 | 25056879 | |
131 | Phosphorylation | DDHLLSPTKGICPKQ CCCCCCCCCCCCCCC | 38.23 | 30266825 | |
132 | Ubiquitination | DHLLSPTKGICPKQE CCCCCCCCCCCCCCC | 50.06 | - | |
137 | Sumoylation | PTKGICPKQENIAGP CCCCCCCCCCCCCCC | 66.87 | 28112733 | |
137 | Ubiquitination | PTKGICPKQENIAGP CCCCCCCCCCCCCCC | 66.87 | - | |
137 (in isoform 2) | Ubiquitination | - | 66.87 | - | |
144 | Ubiquitination | KQENIAGPCRPAQLP CCCCCCCCCCHHHCC | 11.26 | - | |
144 (in isoform 2) | Ubiquitination | - | 11.26 | - | |
156 (in isoform 2) | Ubiquitination | - | 3.45 | - | |
159 | Phosphorylation | AVAPIAASSHPHSSV CCCCCCCCCCCCCHH | 21.84 | 30576142 | |
160 | Phosphorylation | VAPIAASSHPHSSVI CCCCCCCCCCCCHHH | 35.99 | 30576142 | |
164 | Phosphorylation | AASSHPHSSVITSPL CCCCCCCCHHHCHHH | 30.65 | 30576142 | |
165 | Phosphorylation | ASSHPHSSVITSPLR CCCCCCCHHHCHHHH | 17.95 | 30576142 | |
168 | Phosphorylation | HPHSSVITSPLRALG CCCCHHHCHHHHHCC | 23.33 | 30576142 | |
169 | Phosphorylation | PHSSVITSPLRALGA CCCHHHCHHHHHCCC | 15.71 | 28464451 | |
192 | Phosphorylation | CCSARPVSGDGTQGE EEECCEECCCCCCCC | 33.57 | 28111955 | |
196 | Phosphorylation | RPVSGDGTQGEGQTE CEECCCCCCCCCCCC | 37.83 | 28111955 | |
215 | Ubiquitination | CQCQLSGKDEPSSYI CEEEECCCCCCCCEE | 56.39 | - | |
249 | Phosphorylation | NTHGFRIYLEPGPAS HCCCEEEEEECCCCC | 10.76 | 26552605 | |
256 | Phosphorylation | YLEPGPASSSLTPRL EEECCCCCCCCCCCE | 24.48 | 21082442 | |
257 | Phosphorylation | LEPGPASSSLTPRLT EECCCCCCCCCCCEE | 31.32 | 29978859 | |
258 | Phosphorylation | EPGPASSSLTPRLTI ECCCCCCCCCCCEEC | 33.49 | 28348404 | |
260 | Phosphorylation | GPASSSLTPRLTIPP CCCCCCCCCCEECCC | 14.33 | 21082442 | |
262 | Methylation | ASSSLTPRLTIPPPL CCCCCCCCEECCCCC | 38.95 | - | |
264 | Phosphorylation | SSLTPRLTIPPPLGP CCCCCCEECCCCCCH | 32.49 | 28464451 | |
277 | Phosphorylation | GPEAVAQSPLMNFLG CHHHHHCCCCHHHHC | 15.40 | 28464451 | |
286 | Phosphorylation | LMNFLGDSNPFNLLR CHHHHCCCCHHHHHH | 44.60 | - | |
293 | Methylation | SNPFNLLRMTGPILR CCHHHHHHCCCCCCC | 24.63 | - | |
300 | Methylation | RMTGPILRDHPGFGE HCCCCCCCCCCCCCC | 40.69 | - | |
313 | Phosphorylation | GEGRLPGTPPLFSPP CCCCCCCCCCCCCCC | 21.57 | 23898821 | |
318 | Phosphorylation | PGTPPLFSPPPRHHL CCCCCCCCCCCCCCC | 44.15 | 26329039 | |
322 | Asymmetric dimethylarginine | PLFSPPPRHHLDPHR CCCCCCCCCCCCHHH | 35.31 | - | |
322 | Methylation | PLFSPPPRHHLDPHR CCCCCCCCCCCCHHH | 35.31 | - | |
331 | Phosphorylation | HLDPHRLSAEEMGLV CCCHHHCCHHHHCHH | 33.32 | 24850871 | |
343 | Phosphorylation | GLVAQHPSAFDRVMR CHHHCCCHHHHHHHH | 39.17 | 24850871 | |
354 | Sulfoxidation | RVMRLNPMAIDSPAM HHHHHCCCCCCCCCH | 5.06 | 21406390 | |
356 (in isoform 2) | Ubiquitination | - | 4.36 | - | |
358 | Phosphorylation | LNPMAIDSPAMDFSR HCCCCCCCCCHHHHH | 14.40 | 30576142 | |
363 (in isoform 2) | Ubiquitination | - | 3.82 | - | |
364 | Phosphorylation | DSPAMDFSRRLRELA CCCCHHHHHHHHHHH | 16.54 | 30576142 | |
366 (in isoform 2) | Ubiquitination | - | 36.58 | - | |
374 | Phosphorylation | LRELAGNSSTPPPVS HHHHHCCCCCCCCCC | 34.37 | 23401153 | |
375 | Phosphorylation | RELAGNSSTPPPVSP HHHHCCCCCCCCCCC | 49.27 | 30266825 | |
376 | Phosphorylation | ELAGNSSTPPPVSPG HHHCCCCCCCCCCCC | 39.37 | 23401153 | |
381 | Phosphorylation | SSTPPPVSPGRGNPM CCCCCCCCCCCCCHH | 27.66 | 23401153 | |
385 (in isoform 2) | Ubiquitination | - | 48.81 | - | |
398 | Phosphorylation | LLNPFQPSPKSPFLS HCCCCCCCCCCCCCC | 33.89 | 30266825 | |
398 (in isoform 2) | Ubiquitination | - | 33.89 | - | |
400 (in isoform 2) | Ubiquitination | - | 75.09 | - | |
401 | Phosphorylation | PFQPSPKSPFLSTPP CCCCCCCCCCCCCCC | 25.03 | 30576142 | |
405 | Phosphorylation | SPKSPFLSTPPLPPM CCCCCCCCCCCCCCC | 38.97 | 26074081 | |
406 | Phosphorylation | PKSPFLSTPPLPPMP CCCCCCCCCCCCCCC | 30.95 | 28122231 | |
417 | Phosphorylation | PPMPPGGTPPPQPPA CCCCCCCCCCCCCCC | 38.24 | 28348404 | |
426 | Phosphorylation | PPQPPAKSKSCEFCG CCCCCCCCCCCCCCC | 31.72 | 26074081 | |
427 | Ubiquitination | PQPPAKSKSCEFCGK CCCCCCCCCCCCCCC | 59.42 | - | |
428 | Phosphorylation | QPPAKSKSCEFCGKT CCCCCCCCCCCCCCE | 26.43 | 26074081 | |
434 | Acetylation | KSCEFCGKTFKFQSN CCCCCCCCEEEEECC | 52.55 | 23749302 | |
434 | Ubiquitination | KSCEFCGKTFKFQSN CCCCCCCCEEEEECC | 52.55 | - | |
450 | Phosphorylation | IVHRRSHTGEKPYKC EEECCCCCCCCCCCC | 48.56 | 24719451 | |
456 | Ubiquitination | HTGEKPYKCQLCDHA CCCCCCCCCCCCHHH | 24.83 | - | |
465 | Phosphorylation | QLCDHACSQASKLKR CCCHHHHHHHHHHHH | 29.57 | 30576142 | |
468 | Phosphorylation | DHACSQASKLKRHMK HHHHHHHHHHHHHHH | 30.77 | 30576142 | |
469 | Acetylation | HACSQASKLKRHMKT HHHHHHHHHHHHHHH | 62.13 | 25953088 | |
469 | Ubiquitination | HACSQASKLKRHMKT HHHHHHHHHHHHHHH | 62.13 | - | |
480 | Ubiquitination | HMKTHMHKAGSLAGR HHHHHHHHHHCCCCC | 47.03 | - | |
483 | Phosphorylation | THMHKAGSLAGRSDD HHHHHHHCCCCCCCC | 21.65 | 30576142 | |
488 | Phosphorylation | AGSLAGRSDDGLSAA HHCCCCCCCCCCCCC | 38.85 | 30177828 | |
493 | Phosphorylation | GRSDDGLSAASSPEP CCCCCCCCCCCCCCC | 27.58 | 28348404 | |
496 | Phosphorylation | DDGLSAASSPEPGTS CCCCCCCCCCCCCCC | 46.25 | 23401153 | |
497 | Phosphorylation | DGLSAASSPEPGTSE CCCCCCCCCCCCCCH | 28.67 | 22617229 | |
502 | Phosphorylation | ASSPEPGTSELAGEG CCCCCCCCCHHCCCC | 29.73 | 28122231 | |
503 | Phosphorylation | SSPEPGTSELAGEGL CCCCCCCCHHCCCCC | 36.21 | 30576142 | |
514 (in isoform 2) | Ubiquitination | - | 63.15 | - | |
520 (in isoform 2) | Ubiquitination | - | 31.81 | - | |
522 | Phosphorylation | GDFRHHESDPSLGHE CCCCCCCCCCCCCCC | 50.92 | 26074081 | |
525 | Phosphorylation | RHHESDPSLGHEPEE CCCCCCCCCCCCCCC | 52.56 | 26074081 | |
546 (in isoform 2) | Ubiquitination | - | 11.82 | - | |
548 (in isoform 2) | Ubiquitination | - | 53.14 | - | |
550 | Phosphorylation | ELLLENESRPESSFS HHHHCCCCCCCCCCC | 65.79 | - | |
554 (in isoform 2) | Ubiquitination | - | 39.09 | - | |
557 | Phosphorylation | SRPESSFSMDSELSR CCCCCCCCCCHHHHH | 24.51 | - | |
560 | Phosphorylation | ESSFSMDSELSRNRE CCCCCCCHHHHHCCC | 31.62 | - | |
585 | Ubiquitination | GAGGGAAKALADEKA CCCCHHHHHHHHHHH | 43.32 | - | |
591 | Acetylation | AKALADEKALVLGKV HHHHHHHHHHHHHHH | 47.79 | 25953088 | |
591 | Sumoylation | AKALADEKALVLGKV HHHHHHHHHHHHHHH | 47.79 | 28112733 | |
591 | Ubiquitination | AKALADEKALVLGKV HHHHHHHHHHHHHHH | 47.79 | - | |
597 | Ubiquitination | EKALVLGKVMENVGL HHHHHHHHHHHHCCC | 33.96 | - | |
601 (in isoform 2) | Ubiquitination | - | 18.30 | - | |
610 | Phosphorylation | GLGALPQYGELLADK CCCCCCHHHHHHHHH | 15.61 | 28796482 | |
615 (in isoform 2) | Ubiquitination | - | 34.28 | - | |
617 | Acetylation | YGELLADKQKRGAFL HHHHHHHHHHHHHHH | 52.70 | 25953088 | |
617 | Sumoylation | YGELLADKQKRGAFL HHHHHHHHHHHHHHH | 52.70 | 28112733 | |
617 | Ubiquitination | YGELLADKQKRGAFL HHHHHHHHHHHHHHH | 52.70 | - | |
619 | Ubiquitination | ELLADKQKRGAFLKR HHHHHHHHHHHHHHH | 59.55 | - | |
625 | Ubiquitination | QKRGAFLKRAAGGGD HHHHHHHHHHCCCCC | 33.27 | - | |
652 (in isoform 2) | Ubiquitination | - | 33.63 | - | |
662 | Phosphorylation | GGGFAPGTEPFPGLF CCCCCCCCCCCCCCC | 39.15 | - | |
671 | Methylation | PFPGLFPRKPAPLPS CCCCCCCCCCCCCCC | 50.70 | - | |
672 | Ubiquitination | FPGLFPRKPAPLPSP CCCCCCCCCCCCCCC | 45.85 | - | |
678 | Phosphorylation | RKPAPLPSPGLNSAA CCCCCCCCCCCCHHH | 39.00 | 30266825 | |
683 | Phosphorylation | LPSPGLNSAAKRIKV CCCCCCCHHHHHCCC | 34.35 | 30576142 | |
686 | Acetylation | PGLNSAAKRIKVEKD CCCCHHHHHCCCCCC | 55.14 | 25953088 | |
686 | Sumoylation | PGLNSAAKRIKVEKD CCCCHHHHHCCCCCC | 55.14 | 28112733 | |
686 | Ubiquitination | PGLNSAAKRIKVEKD CCCCHHHHHCCCCCC | 55.14 | - | |
689 | Ubiquitination | NSAAKRIKVEKDLEL CHHHHHCCCCCCCCC | 48.66 | - | |
719 (in isoform 2) | Ubiquitination | - | 23.49 | - | |
723 | Sumoylation | AASRHFMKDPFLGFT HHHHHHHCCCCCCCC | 62.40 | 28112733 | |
723 | Ubiquitination | AASRHFMKDPFLGFT HHHHHHHCCCCCCCC | 62.40 | - | |
730 | Phosphorylation | KDPFLGFTDARQSPF CCCCCCCCCCCCCCC | 27.27 | 26074081 | |
732 (in isoform 2) | Ubiquitination | - | 14.35 | - | |
735 | Phosphorylation | GFTDARQSPFATSSE CCCCCCCCCCCCCCC | 19.21 | 30576142 | |
735 (in isoform 2) | Ubiquitination | - | 19.21 | - | |
739 | Phosphorylation | ARQSPFATSSEHSSE CCCCCCCCCCCCCCC | 32.91 | 26074081 | |
740 | Phosphorylation | RQSPFATSSEHSSEN CCCCCCCCCCCCCCC | 30.24 | 26074081 | |
741 | Phosphorylation | QSPFATSSEHSSENG CCCCCCCCCCCCCCC | 34.67 | 26074081 | |
744 | Phosphorylation | FATSSEHSSENGSLR CCCCCCCCCCCCCEE | 34.98 | 26074081 | |
745 | Phosphorylation | ATSSEHSSENGSLRF CCCCCCCCCCCCEEE | 36.67 | 26074081 | |
749 | Phosphorylation | EHSSENGSLRFSTPP CCCCCCCCEEECCCC | 28.14 | 26074081 | |
751 | Methylation | SSENGSLRFSTPPGD CCCCCCEEECCCCCC | 25.76 | - | |
753 | Phosphorylation | ENGSLRFSTPPGDLL CCCCEEECCCCCCCC | 33.30 | 23401153 | |
754 | Phosphorylation | NGSLRFSTPPGDLLD CCCEEECCCCCCCCC | 30.69 | 30266825 | |
754 (in isoform 2) | Ubiquitination | - | 30.69 | - | |
765 | Phosphorylation | DLLDGGLSGRSGTAS CCCCCCCCCCCCCCC | 35.12 | 26074081 | |
767 (in isoform 2) | Ubiquitination | - | 28.65 | - | |
768 | Phosphorylation | DGGLSGRSGTASGGS CCCCCCCCCCCCCCC | 43.98 | 28348404 | |
770 | Phosphorylation | GLSGRSGTASGGSTP CCCCCCCCCCCCCCC | 20.92 | 28348404 | |
772 | Phosphorylation | SGRSGTASGGSTPHL CCCCCCCCCCCCCCC | 43.45 | 23401153 | |
775 | Phosphorylation | SGTASGGSTPHLGGP CCCCCCCCCCCCCCC | 42.14 | 23401153 | |
776 | Phosphorylation | GTASGGSTPHLGGPG CCCCCCCCCCCCCCC | 20.29 | 28348404 | |
780 (in isoform 2) | Ubiquitination | - | 36.90 | - | |
788 | Phosphorylation | GPGPGRPSSKEGRRS CCCCCCCCCCCCCCC | 53.32 | 23401153 | |
789 | Phosphorylation | PGPGRPSSKEGRRSD CCCCCCCCCCCCCCC | 37.09 | 30576142 | |
790 | Ubiquitination | GPGRPSSKEGRRSDT CCCCCCCCCCCCCCC | 69.40 | - | |
795 | Phosphorylation | SSKEGRRSDTCEYCG CCCCCCCCCCCHHHH | 35.59 | 30576142 | |
797 | Phosphorylation | KEGRRSDTCEYCGKV CCCCCCCCCHHHHHH | 14.42 | 28111955 | |
800 (in isoform 2) | Ubiquitination | - | 14.51 | - | |
803 | Acetylation | DTCEYCGKVFKNCSN CCCHHHHHHHHHCCC | 40.72 | 25953088 | |
803 | Ubiquitination | DTCEYCGKVFKNCSN CCCHHHHHHHHHCCC | 40.72 | - | |
803 (in isoform 2) | Ubiquitination | - | 40.72 | - | |
804 (in isoform 2) | Ubiquitination | - | 5.11 | - | |
806 | Ubiquitination | EYCGKVFKNCSNLTV HHHHHHHHHCCCCEE | 61.09 | - | |
809 | Phosphorylation | GKVFKNCSNLTVHRR HHHHHHCCCCEEECC | 44.24 | - | |
816 (in isoform 2) | Ubiquitination | - | 20.22 | - | |
817 | Phosphorylation | NLTVHRRSHTGERPY CCEEECCCCCCCCCE | 25.92 | 24719451 | |
819 | Phosphorylation | TVHRRSHTGERPYKC EEECCCCCCCCCEEC | 41.82 | 28464451 | |
825 | Ubiquitination | HTGERPYKCELCNYA CCCCCCEECEECCHH | 24.74 | - | |
838 | Acetylation | YACAQSSKLTRHMKT HHHHCCHHHHHHHHH | 60.16 | 25953088 | |
838 | Ubiquitination | YACAQSSKLTRHMKT HHHHCCHHHHHHHHH | 60.16 | - | |
840 | Phosphorylation | CAQSSKLTRHMKTHG HHCCHHHHHHHHHHC | 23.43 | 30576142 | |
844 | Ubiquitination | SKLTRHMKTHGQIGK HHHHHHHHHHCCCCC | 31.11 | - | |
851 | Acetylation | KTHGQIGKEVYRCDI HHHCCCCCEEEECCC | 45.71 | 19608861 | |
851 | Ubiquitination | KTHGQIGKEVYRCDI HHHCCCCCEEEECCC | 45.71 | 19608861 | |
854 | Phosphorylation | GQIGKEVYRCDICQM CCCCCEEEECCCCCC | 13.45 | 30576142 | |
864 | Phosphorylation | DICQMPFSVYSTLEK CCCCCCCCHHHHHHH | 17.80 | 21406692 | |
866 | Phosphorylation | CQMPFSVYSTLEKHM CCCCCCHHHHHHHHH | 8.50 | 21406692 | |
867 | Phosphorylation | QMPFSVYSTLEKHMK CCCCCHHHHHHHHHH | 25.10 | 21406692 | |
868 | Phosphorylation | MPFSVYSTLEKHMKK CCCCHHHHHHHHHHH | 22.65 | 21406692 | |
871 | Ubiquitination | SVYSTLEKHMKKWHG CHHHHHHHHHHHHCC | 52.70 | - | |
875 | Ubiquitination | TLEKHMKKWHGEHLL HHHHHHHHHCCHHHC | 36.53 | - | |
887 | Sumoylation | HLLTNDVKIEQAERS HHCCCCCCHHHHHCC | 43.31 | 28112733 | |
887 | Ubiquitination | HLLTNDVKIEQAERS HHCCCCCCHHHHHCC | 43.31 | - | |
894 | Phosphorylation | KIEQAERS------- CHHHHHCC------- | 35.76 | 24719451 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
2 | S | Phosphorylation | Kinase | PRKCA | P17252 | GPS |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of BC11B_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of BC11B_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
CHD4_HUMAN | CHD4 | physical | 16091750 | |
MTA2_HUMAN | MTA2 | physical | 16091750 | |
MTA1_HUMAN | MTA1 | physical | 16091750 | |
RBBP7_HUMAN | RBBP7 | physical | 16091750 | |
RBBP4_HUMAN | RBBP4 | physical | 16091750 | |
HDAC2_HUMAN | HDAC2 | physical | 16091750 | |
HDAC1_HUMAN | HDAC1 | physical | 16091750 | |
MBD3_HUMAN | MBD3 | physical | 16091750 | |
COT1_HUMAN | NR2F1 | physical | 15849318 | |
SP1_HUMAN | SP1 | physical | 15849318 | |
HDAC1_HUMAN | HDAC1 | physical | 17245431 | |
HDAC2_HUMAN | HDAC2 | physical | 17245431 | |
HDAC3_HUMAN | HDAC3 | physical | 17245431 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-851, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-97; THR-120; SER-256;THR-260; SER-277; THR-313; SER-318; SER-358; THR-376; SER-381;THR-417; SER-483; SER-488; SER-493; SER-496; SER-497; SER-678; THR-754AND SER-765, AND MASS SPECTROMETRY. | |
"Phosphorylation analysis of primary human T lymphocytes usingsequential IMAC and titanium oxide enrichment."; Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.; J. Proteome Res. 7:5167-5176(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-772, AND MASSSPECTROMETRY. |